Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations

2017-01-10

Storr, Julie

Twyman, Anthony

Zingg, Walter

Damani, Nizam

Kilpatrick, Claire

Reilly, Jacqui

Price, Lesley

Egger, Matthias

Grayson, M Lindsay

Kelley, Edward

Allegranzi, Benedetta

WHO Guidelines Development Group

Infection prevention and control

HAI

IPC programmes

Hand hygiene

Antimicrobial resistance

IPC guideline

Surveillance

Multimodal strategy

IPC education

Workload

Staffing

Workforce

Bed occupancy

IPC practices

Universal health coverage

Journal Article

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

10.1186/s13756-016-0149-9

Health care-associated infections (HAI) are a major public health problem with a significant impact on morbidity, mortality and quality of life. They represent also an important economic burden to health systems worldwide. However, a large proportion of HAI are preventable through effective infection prevention and control (IPC) measures. Improvements in IPC at the national and facility level are critical for the successful containment of antimicrobial resistance and the prevention of HAI, including outbreaks of highly transmissible diseases through high quality care within the context of universal health coverage. Given the limited availability of IPC evidence-based guidance and standards, the World Health Organization (WHO) decided to prioritize the development of global recommendations on the core components of effective IPC programmes both at the national and acute health care facility level, based on systematic literature reviews and expert consensus. The aim of the guideline development process was to identify the evidence and evaluate its quality, consider patient values and preferences, resource implications, and the feasibility and acceptability of the recommendations. As a result, 11 recommendations and three good practice statements are presented here, including a summary of the supporting evidence, and form the substance of a new WHO IPC guideline.

link

Antimicrobial Resistance & Infection Control 2017; 6: 6

Antimicrobial Resistance & Infection Control